
China SXT Pharmaceuticals SXTC
$ 1.66
-5.68%
Annual report 2025
added 04-25-2026
China SXT Pharmaceuticals ROCE Ratio 2011-2026 | SXTC
Annual ROCE Ratio China SXT Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -17.13 | -17.68 | -37.24 | - | -13.76 | -14.21 | 15.87 | 49.68 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 49.68 | -37.24 | -4.92 |
ROCE Ratio of other stocks in the Biotechnology industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-299.89 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
64924.32 | - | -10.17 % | $ 12.2 K | ||
|
Midatech Pharma plc
MTP
|
-337.43 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-325.06 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
-49.48 | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-0.65 | $ 0.8 | -3.59 % | $ 36.6 M | ||
|
Athira Pharma
ATHA
|
-368.0 | - | - | $ 269 M | ||
|
Exelixis
EXEL
|
40.35 | $ 46.21 | -5.11 % | $ 12.5 B | ||
|
Fortress Biotech
FBIO
|
-140.8 | $ 2.4 | -5.88 % | $ 67 M | ||
|
Forte Biosciences
FBRX
|
-115.85 | $ 26.17 | -1.32 % | $ 339 M | ||
|
Heron Therapeutics
HRTX
|
-17.71 | $ 1.24 | -5.34 % | $ 207 M | ||
|
Ionis Pharmaceuticals
IONS
|
-43.85 | $ 76.02 | -1.08 % | $ 12.2 B | ||
|
BioNTech SE
BNTX
|
-4.81 | $ 93.02 | -2.35 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-88.5 | - | - | $ 231 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
-2.72 | $ 210.33 | -9.55 % | $ 3.85 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
31.5 | $ 22.57 | 5.05 % | $ 3.74 B | ||
|
Mirum Pharmaceuticals
MIRM
|
-7.03 | $ 102.93 | -6.5 % | $ 5.17 B | ||
|
MannKind Corporation
MNKD
|
-76.05 | $ 3.55 | -0.28 % | $ 1.09 B | ||
|
Advaxis
ADXS
|
429.74 | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
-19.96 | $ 3.14 | -0.32 % | $ 653 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-146.69 | $ 3.54 | 5.67 % | $ 5.83 M | ||
|
Aeterna Zentaris
AEZS
|
-29.95 | - | 5.93 % | $ 314 M | ||
|
Genprex
GNPX
|
-194.87 | $ 0.87 | -2.84 % | $ 811 K | ||
|
Matinas BioPharma Holdings
MTNB
|
-121.15 | $ 0.65 | -5.15 % | $ 3.56 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-29.3 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-51.5 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-60.13 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-80.33 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-38.05 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
-46.69 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-163.42 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-37.16 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
-116.14 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-58.56 | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-6.45 | $ 20.66 | -14.52 % | $ 2.63 B | ||
|
Allena Pharmaceuticals
ALNA
|
-252.54 | - | 3.16 % | $ 1.9 M | ||
|
Genmab A/S
GMAB
|
31.74 | $ 27.06 | -2.98 % | $ 16.7 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-75.24 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.41 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
-299.27 | - | 10.36 % | $ 9.8 M | ||
|
Applied Therapeutics
APLT
|
394.73 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
-664.7 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
123.77 | - | 17.91 % | $ 11.1 M |